David Grossman serves as Executive at AIT Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, David Grossman has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 16, 2018 involved exercising options for 2,342 shares valued at $10.0K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Feb 16, 2018 | AITB | $10.0K | Option Exercise | 2,342 | $4.25 | Discretionary |
David Grossman currently holds 4,008 shares of AIT Therapeutics, Inc. (AITB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Grossman has been a net neutral trader of AITB stock. They have purchased $0 and sold $0 worth of shares.
David Grossman's most recent insider trade was on Feb 16, 2018, when they sold 2,342 shares at $4.25 per share.
Get notified when new Form 4 filings are submitted